Real‐world data on safety and efficacy of venetoclax‐based regimens in relapsed/refractory t(11;14) multiple myeloma

por Basali, Diana, Chakraborty, Rajshekhar, Rybicki, Lisa, Rosko, Nathaniel, Reed, Janice, Karam, Maryann, Schlueter, Kristen, Dysert, Hayley, Kalaycio, Matt, Valent, Jason
Publicado 2020

Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma

por Chakraborty, Rajshekhar, Rybicki, Lisa, Nakashima, Megan O., Dean, Robert M., Faiman, Beth M., Samaras, Christy J., Rosko, Nathaniel, Dysert, Hayley, Valent, Jason, Anwer, Faiz
Publicado 2020

Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development

por Iftikhar, Ahmad, Hassan, Hamza, Iftikhar, Nimra, Mushtaq, Adeela, Sohail, Atif, Rosko, Nathaniel, Chakraborty, Rajshekhar, Razzaq, Faryal, Sandeep, Sonia, Valent, Jason Neil, Kanate, Abraham Sebastian, Anwer, Faiz
Publicado 2019